The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Serum NT pro-BNP and individual genetic polymorphisms as predictors of trastuzumab-related cardiotoxicity.
S. Goel
No relevant relationships to disclose
J. Lynch
No relevant relationships to disclose
L. A. Chantrill
No relevant relationships to disclose
J. J. Rutovitz
No relevant relationships to disclose
B. Murray
No relevant relationships to disclose
E. A. Abdi
No relevant relationships to disclose
R. Bell
No relevant relationships to disclose
A. L. Sullivan
No relevant relationships to disclose
A. Goldrick
No relevant relationships to disclose
T. M. Hayes
No relevant relationships to disclose
G. Asghari
No relevant relationships to disclose
N. Wilcken
No relevant relationships to disclose
N. J. McCarthy
No relevant relationships to disclose
J. M. Beith
No relevant relationships to disclose